查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1916293

輸液袋市場按產品類型、包裝材料、容量、最終用戶和分銷管道分類－2026-2032年全球預測

IV Fluid Bags Market by Product Type, Packaging Material, Bag Volume, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，輸液袋市場價值將達到 72.5 億美元，到 2026 年將成長至 76.7 億美元，到 2032 年將達到 121.5 億美元，年複合成長率為 7.65%。

關鍵市場統計數據
基準年 2025 72.5億美元
預計年份：2026年 76.7億美元
預測年份 2032 121.5億美元
複合年成長率 (%) 7.65%

全面了解不斷發展的靜脈輸液袋領域，其中臨床需求、供應穩定性以及材料創新正在重新定義策略重點。

靜脈輸液袋領域正處於一個關鍵的轉折點，臨床需求、不斷變化的法規和材料創新在此交匯融合，重塑供應商的策略和採購行為。臨床醫生在選擇配方和包裝形式時，始終將患者安全和適用性放在首位。同時，採購和供應鏈團隊必須平衡這些臨床需求與對材料永續性和一次性醫療器材管理日益嚴格的審查。此外，製造商也在調整其生產佈局和技術架構，以服務更廣泛的終端用戶群體，從高風險重症醫院到居家醫療機構。

材料替代、分散式照護環境、永續性優先事項和供應鏈重組如何共同改變靜脈輸液袋策略

受材料替代、監管壓力和臨床護理環境重塑的驅動，靜脈輸液袋市場環境正經歷多重變化。首先，傳統的PVC包裝正明顯轉向非PVC替代品。這主要得益於生物聚合物薄膜和乙烯-醋酸乙烯酯共聚物（EVA）技術的進步，這些技術有望提高安全性並減少可萃取物。這種材料轉變正在影響配方相容性、滅菌方法和生產工具，從而推動資本投資和新的供應商夥伴關係。

評估 2025 年美國關稅政策對輸液袋的採購、製造在地化和供應鏈韌性的多面向連鎖反應。

美國關稅將於2025年生效，對輸液袋的採購、生產和全球分銷管道產生了複雜的連鎖反應。在採購層面，關稅帶來的成本壓力迫使採購商重新評估其供應商組合，並考慮優先考慮降低關稅負擔的替代籌資策略。為此，供應鏈團隊正在加快對本地及周邊製造商的資質認證，並加強長期合約、避險和供應商管理庫存（VMI）等事宜的談判，以降低價格波動風險。

一個整合的細分框架，將製劑分類、臨床應用、包裝材料、容量通路和分銷管道與營運和臨床決策促進因素連結起來。

透過精細的市場區隔方法，可以清楚地揭示輸液袋市場的需求促進因素和技術限制，從而指導產品開發、商業化和籌資策略。依產品類型，此市場可分為膠體和晶體兩大類。膠體包括白蛋白、聚葡萄糖、明膠和羥乙基澱粉，每種膠體都有其獨特的臨床適應症和穩定性考慮；晶體包括葡萄糖、生理食鹽水水和乳酸林格氏液，這些都是復甦和常規維持治療的基礎。這種產品細分決定了不同輸液袋材料和滅菌方法的配方相容性，進而影響包裝選擇和監管文件。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和監管環境將決定供應策略、採用模式和合規方法。

區域趨勢將對輸液袋的供應韌性、監管路徑和市場接受度產生決定性影響，進而影響生產商和採購商的策略重點。在美洲，先進的醫院網路和大規模綜合醫療保健系統對各種配方和容量的輸液袋產生了集中需求，而區域供應商和契約製造製造商則致力於滿足嚴格的監管和品質要求。該地區也出現了永續性標準加速普及和產品責任延伸計畫不斷擴大的趨勢，這將影響包裝材料的選擇和處置方式。

靜脈輸液袋市場競爭格局：規模、材料創新、監管應對力和靈活的區域供應模式將決定市場領導地位的趨勢

輸液袋市場的競爭格局取決於產品創新、生產規模、通路和監管能力。成熟的跨國製造商在檢驗的生產流程、全球監管文件和廣泛的分銷網路方面擁有優勢，使其能夠服務複雜的醫院系統和大型採購集團。同時，專業的區域供應商和契約製造製造商則提供靈活性和本地化應對力，通常能夠幫助尋求關稅減免或近岸採購的醫療系統加快認證週期。

為確保供應韌性、檢驗替代材料以及調整產品系列以適應分散式醫療保健服務，製造商和負責人可採取切實可行的、優先考慮的策略行動。

產業領導者應採取多管齊下的策略，將臨床優先事項與穩健的供應鏈設計和材料創新相結合。首先，透過與臨床合作夥伴和輸液設備供應商合格進行檢驗項目，加速非PVC包裝方案的認證，以證明其在常用給藥系統中的兼容性、無菌性和臨床安全性。這將降低採用門檻，並使供應商能夠滿足日益成長的永續性和安全性要求。其次，實現製造地多元化，納入近岸和區域性選項，以便快速應對關稅波動和物流中斷。同時，維持品質系統的一致性和重點監管至關重要。

我們採用了嚴謹的混合調查方法，結合了關鍵相關人員訪談、設施檢驗、技術文獻綜述和情境分析，以提供可靠的策略見解。

我們的研究途徑整合了定性和定量證據，旨在對輸液袋市場趨勢形成切實可行的理解。主要研究包括對採購主管、臨床藥師、法規事務專家和生產主管進行結構化訪談，以收集有關供應鏈脆弱性、材料偏好和實施障礙的第一手觀點。此外，我們也結合了生產和包裝設施的現場考察和流程審核，以檢驗生產流程和品管措施。

從策略層面整合關鍵的臨床、材料和供應鏈問題，以確定輸液解決方案永續取得和創新的可行優先事項。

總而言之，在材料創新、醫療服務模式變革、永續性以及貿易政策趨勢等多重壓力下，靜脈輸液袋產業正在不斷發展。這些因素迫使製造商重新思考包裝材料，調整製造地，並加強與臨床和採購相關人員的合作。同時，買家要求提高材料透明度、無菌保證以及全生命週期影響的透明度，這凸顯了檢驗的非PVC解決方案和靈活的分銷模式對於支持門診和居家醫療的重要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依產品類型分類的輸液袋市場

  • 膠體
    • 白蛋白
    • 聚葡萄糖
    • 明膠
    • 羥乙基澱粉
  • 晶體溶液
    • 葡萄糖
    • 生理食鹽水
    • 林格氏乳酸鹽溶液

9. 按包裝材料分類的輸液袋市場

  • 不含聚氯乙烯
    • 生物聚合物薄膜
    • 乙烯-醋酸乙烯酯
  • PVC

第10章 依輸液袋容量分類的輸液袋市場

  • 100～250 mL
  • 250-500 mL
  • 500～1000 mL
  • 超過1000毫升

第11章 依終端用戶分類的輸液袋市場

  • 門診手術中心
  • 診所
  • 居家醫療
  • 醫院

第12章 按分銷管道分類的輸液袋市場

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第13章 輸液袋市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 輸液袋市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國輸液袋市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章美國輸液袋市場

第17章 中國輸液袋市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Amcor Limited
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius Kabi AG
  • Grifols, SA
  • Hikma Pharmaceuticals PLC
  • ICU Medical, Inc.
  • Kraton Corporation
  • Nipro Corporation
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Terumo Corporation
  • Wipak Group
Product Code: MRR-AE420CB1535B

The IV Fluid Bags Market was valued at USD 7.25 billion in 2025 and is projected to grow to USD 7.67 billion in 2026, with a CAGR of 7.65%, reaching USD 12.15 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.25 billion
Estimated Year [2026] USD 7.67 billion
Forecast Year [2032] USD 12.15 billion
CAGR (%) 7.65%

A comprehensive orientation to the evolving intravenous fluid bag domain where clinical imperatives, supply resilience, and material innovation are redefining strategic priorities

The intravenous fluid bag sector is at a pivotal intersection where clinical demand, regulatory evolution, and materials innovation converge to reshape supplier strategies and procurement behavior. Clinicians continue to prioritize patient safety and compatibility when selecting formulations and packaging formats, while procurement and supply-chain teams must reconcile these clinical needs with rising scrutiny around material sustainability and single-use device stewardship. In parallel, manufacturers are adapting production footprints and technology stacks to serve a more diversified set of end users, from high-acuity hospitals to home healthcare settings.

Consequently, stakeholders across the value chain face a broadened decision horizon: procurement teams must assess total lifecycle impacts and compatibility with infusion systems, clinical teams must balance therapeutic profiles with fluid selection protocols, and regulatory affairs groups must navigate a tightening framework for device and packaging approval. Moreover, the industry landscape is being influenced by raw material availability and environmental concerns that accelerate the shift toward alternative polymers. As a result, strategic clarity is now a competitive differentiator; organizations that translate operational resilience, material science, and clinical alignment into pragmatic product and supply strategies will be best positioned to navigate near-term disruptions and longer-term structural shifts.

How material substitution, care-setting decentralization, sustainability priorities, and supply-chain realignment are jointly transforming intravenous fluid bag strategies

The landscape for intravenous fluid bags is undergoing several transformative shifts driven by material substitution, regulatory pressure, and a reconfiguration of clinical care settings. First, there is a clear movement away from legacy PVC-based packaging toward non-PVC alternatives, led by advances in biopolymer films and ethylene vinyl acetate technologies that promise improved safety profiles and reduced leachables. This material transition is affecting formulation compatibility, sterilization practices, and production tooling, prompting capital investments and new vendor partnerships.

Second, the distribution and point-of-care paradigm is diversifying as ambulatory surgical centers and home healthcare expand their utilization of intravenous therapies. This change compels manufacturers to offer a broader range of bag volumes and packaging formats that support safe administration outside of traditional inpatient settings. Third, environmental and sustainability metrics are increasingly embedded into procurement criteria, influencing purchasing decisions and supplier scorecards. Finally, geopolitical dynamics and trade policy shifts are accelerating supply-chain reconfiguration, creating opportunities for regional manufacturing hubs and contract manufacturing specialization. Taken together, these shifts are not isolated; they interact to drive R&D priorities, influence clinical protocols, and create new criteria for supplier selection that favor adaptable, compliance-ready partners.

Assessing the multifaceted ripple effects of 2025 United States tariff policies on procurement, manufacturing localization, and supply-chain resiliency for intravenous fluid bags

United States tariff measures implemented in 2025 have introduced a complex set of cascading effects that extend across procurement, manufacturing, and global distribution channels for intravenous fluid bags. On a procurement level, tariff-induced cost pressures have forced buyers to reassess supplier portfolios and evaluate alternative sourcing strategies that prioritize tariff exposure minimization. In response, supply teams have accelerated qualification of regional and nearshore manufacturers and intensified negotiations around long-term agreements, hedging, and vendor-managed inventory arrangements to mitigate volatility.

At the manufacturing level, tariffs have prompted a renewed focus on localization and vertically integrated supply models. Manufacturers are evaluating the trade-offs between relocating final assembly versus reshaping upstream supply chains for polymers and additives to reduce tariff incidence. This has also sharpened interest in contract manufacturing partners with multi-jurisdictional footprints that can shift production with limited disruption. Furthermore, tariff-driven cost dynamics have catalyzed innovation in materials efficiency and packaging design to preserve margins without sacrificing clinical performance.

Regulatory and procurement teams have felt indirect impacts, as cost pass-through pressures intersect with hospital budgeting cycles and reimbursement frameworks. This convergence has increased scrutiny of total cost of ownership calculations and the operational implications of switching packaging types or suppliers. In sum, tariff policies have accelerated strategic planning horizons, encouraged diversification of supply chains, and reinforced the importance of resilient procurement solutions that integrate material, regulatory, and logistical considerations into sourcing decisions.

Integrated segmentation framework linking formulation classes, care settings, packaging materials, volume ranges, and distribution channels to operational and clinical decision drivers

A refined segmentation approach reveals distinct demand drivers and technical constraints that inform product development, commercialization, and procurement strategies across the intravenous fluid bag landscape. Based on product type, the domain divides into colloid and crystalloid formulations; colloids encompass albumin, dextrans, gelatins, and hydroxyethyl starch, each with unique clinical indications and stability considerations, while crystalloids include dextrose, normal saline, and Ringer's lactate, which are foundational to resuscitation and routine maintenance therapies. This product segmentation dictates formulation compatibility with different bag materials and sterilization regimes, thereby influencing packaging choices and regulatory documentation.

Based on end user, demand profiles vary significantly across ambulatory surgical centers, clinics, home healthcare, and hospitals, with each setting exhibiting distinct volume rhythms, handling practices, and storage constraints that shape bag volume preferences and distribution models. Based on packaging material, the industry is bifurcated into non-PVC and PVC options; the non-PVC cohort further comprises biopolymer films and ethylene vinyl acetate, which present advantages for reducing plasticizer exposure and improving environmental credentials but require adaptation in manufacturing processes and supplier assurance programs.

Based on bag volume, product offerings span ranges from 100-250 mL to 250-500 mL, 500-1000 mL, and volumes above 1000 mL, with clinical protocols and point-of-care settings driving preferred sizes. Lastly, based on distribution channel, product availability and purchasing behavior are shaped by hospital pharmacy, online pharmacy, and retail pharmacy routes that impose different regulatory, packaging, and logistics requirements. Integrating these segmentation lenses enables a differentiated approach to portfolio design, inventory management, and clinical engagement strategies.

Regional dynamics and regulatory landscapes across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine supply strategies, adoption patterns, and compliance approaches

Regional dynamics exert a decisive influence on supply resilience, regulatory pathways, and adoption curves for intravenous fluid bags, shaping strategic priorities across manufacturers and buyers. In the Americas, advanced hospital networks and large integrated health systems create concentrated demand for a broad range of formulations and volumes, while regional suppliers and contract manufacturers work to meet stringent regulatory and quality expectations. This region also exhibits accelerated adoption of sustainability criteria and extended product stewardship programs that influence packaging material choices and end-of-life considerations.

Europe, Middle East & Africa present a heterogeneous landscape where regulatory harmonization in some jurisdictions coexists with fragmented procurement practices in others, requiring manufacturers to engage in nuanced market access strategies. In these markets, stakeholder expectations around patient safety, material biocompatibility, and local manufacturing content influence both clinical adoption and purchasing decisions. Meanwhile, the Asia-Pacific region is characterized by dynamic capacity expansion, diverse clinical infrastructures, and rapid uptake of home healthcare services, driving demand for varied bag volumes and adaptable packaging solutions; local production capabilities and government procurement policies also play a pivotal role in shaping competitive positioning. Across these geographies, differing regulatory timelines, supply-chain architectures, and sustainability mandates necessitate region-specific commercialization, manufacturing, and supply strategies to ensure timely access and compliance.

Competitive anatomy of the intravenous fluid bag arena where scale, material innovation, regulatory expertise, and agile regional supply models determine market leadership dynamics

Competitive dynamics in the intravenous fluid bag space are shaped by product innovation, manufacturing scale, distribution breadth, and regulatory competency. Established multinational manufacturers maintain advantages in validated production processes, global regulatory dossiers, and broad distribution networks, enabling them to serve complex hospital systems and large procurement groups. At the same time, specialized regional suppliers and contract manufacturers provide agility and localized responsiveness, often supporting rapid qualification cycles for health systems seeking reduced tariff exposure or nearshore sourcing.

Innovation is concentrated not only in formulation optimization but also in packaging and sterilization technology, where advancements in non-PVC biopolymer films and ethylene vinyl acetate materials have created distinct product families that appeal to safety- and sustainability-driven buyers. Strategic partnerships and co-development agreements between material science firms and infusion device manufacturers are increasingly common as firms seek to validate compatibility across administration sets and infusion pumps. Additionally, private-label and private-brand strategies adopted by large health systems and pharmacy groups are influencing demand patterns, pressuring traditional suppliers to offer differentiated service models, value-added logistics, and bundled clinical support. Overall, success in this environment favors companies that combine technical excellence, regulatory rigor, flexible manufacturing footprints, and deep engagement with clinical and procurement stakeholders.

Practical, prioritized strategic actions for manufacturers and buyers to secure supply resilience, validate alternative materials, and align product portfolios with decentralized care delivery

Industry leaders should pursue a multifaceted strategy that aligns clinical priorities with resilient supply-chain design and material innovation. First, accelerate qualification of non-PVC packaging options by investing in joint validation programs with clinical partners and infusion device vendors to demonstrate compatibility, sterility retention, and clinical safety across common administration systems. This will reduce adoption friction and position suppliers to meet growing sustainability and safety requirements. Second, diversify manufacturing footprints to include nearshore and regional options that can be scaled rapidly in response to tariff shifts or logistic interruptions, while maintaining consistent quality systems and centralized regulatory oversight.

Third, establish integrated procurement solutions that combine long-term supply agreements with flexible volume commitments and vendor-managed inventory models to smooth demand variability across ambulatory centers, hospitals, and home healthcare channels. Fourth, enhance engagement with hospital pharmacy and outpatient pharmacy stakeholders by offering tailored packaging volumes and educational initiatives that support safe handling in decentralized care settings. Fifth, invest in traceability and lifecycle assessment capabilities to provide purchasers with transparent data on material composition, sterilization validation, and end-of-life disposal options, thereby aligning with evolving procurement criteria. Finally, prioritize collaborative R&D with material science partners to improve polymer performance and reduce dependence on constrained raw materials, thereby protecting margins and enabling continuous product innovation.

A rigorous mixed-methods research approach combining primary stakeholder interviews, facility validation, technical literature review, and scenario analysis for dependable strategic insights

The research approach combined qualitative and quantitative evidence streams to develop robust, actionable insight into intravenous fluid bag dynamics. Primary research included structured interviews with procurement leaders, clinical pharmacists, regulatory affairs professionals, and manufacturing executives to capture first-hand perspectives on supply-chain vulnerabilities, material preferences, and adoption barriers. These interviews were complemented by site visits and process audits at manufacturing and packaging facilities to validate production workflows and quality management practices.

Secondary research focused on regulatory guidance, published clinical literature, and materials science studies to assess compatibility considerations and safety profiles for different polymers and formulations. Data triangulation was applied to reconcile primary observations with published technical evidence and supplier disclosures, ensuring conclusions reflected both market practice and technical feasibility. Scenario analysis was used to model the operational impacts of tariff policies, material supply interruptions, and shifts in care delivery, enabling the development of practical mitigation pathways. Finally, validation workshops with cross-functional stakeholders refined recommendations and ensured that proposed actions were operationally and clinically feasible within existing procurement and regulatory frameworks.

Strategic synthesis of clinical, material, and supply-chain imperatives that defines the actionable priorities for sustained access and innovation in intravenous fluid solutions

In summary, the intravenous fluid bag domain is evolving under the combined pressures of material innovation, shifting care delivery models, sustainability mandates, and trade policy dynamics. These forces are prompting manufacturers to rethink packaging materials, adjust manufacturing footprints, and deepen engagement with clinical and procurement stakeholders. At the same time, buyers are demanding greater transparency around materials, sterility assurance, and total lifecycle implications, which is elevating the importance of validated non-PVC solutions and flexible distribution models that support ambulatory and home-based care.

Going forward, success will depend on the ability of organizations to integrate clinical validation, regulatory readiness, and supply-chain resilience into coherent commercialization and sourcing strategies. Those that proactively qualify alternative materials, diversify production geographies, and provide clear evidence of compatibility and environmental performance will reduce operational risk and better meet the evolving priorities of health systems. Ultimately, the most effective responses will be collaborative, balancing technical innovation with pragmatic supply arrangements and targeted clinical engagement to ensure safe and reliable access to intravenous therapies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. IV Fluid Bags Market, by Product Type

  • 8.1. Colloid
    • 8.1.1. Albumin
    • 8.1.2. Dextrans
    • 8.1.3. Gelatins
    • 8.1.4. Hydroxyethyl Starch
  • 8.2. Crystalloid
    • 8.2.1. Dextrose
    • 8.2.2. Normal Saline
    • 8.2.3. Ringers Lactate

9. IV Fluid Bags Market, by Packaging Material

  • 9.1. Non-PVC
    • 9.1.1. Biopolymer Films
    • 9.1.2. Ethylene Vinyl Acetate
  • 9.2. PVC

10. IV Fluid Bags Market, by Bag Volume

  • 10.1. 100-250 mL
  • 10.2. 250-500 mL
  • 10.3. 500-1000 mL
  • 10.4. Above 1000 mL

11. IV Fluid Bags Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Home Healthcare
  • 11.4. Hospitals

12. IV Fluid Bags Market, by Distribution Channel

  • 12.1. Hospital Pharmacy
  • 12.2. Online Pharmacy
  • 12.3. Retail Pharmacy

13. IV Fluid Bags Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. IV Fluid Bags Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. IV Fluid Bags Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States IV Fluid Bags Market

17. China IV Fluid Bags Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Amcor Limited
  • 18.6. B. Braun Melsungen AG
  • 18.7. Baxter International Inc.
  • 18.8. Fresenius Kabi AG
  • 18.9. Grifols, S.A.
  • 18.10. Hikma Pharmaceuticals PLC
  • 18.11. ICU Medical, Inc.
  • 18.12. Kraton Corporation
  • 18.13. Nipro Corporation
  • 18.14. Otsuka Pharmaceutical Co., Ltd.
  • 18.15. Pfizer Inc.
  • 18.16. Terumo Corporation
  • 18.17. Wipak Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL IV FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IV FLUID BAGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL IV FLUID BAGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL IV FLUID BAGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL IV FLUID BAGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IV FLUID BAGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES IV FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA IV FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL IV FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL IV FLUID BAGS MARKET SIZE, BY COLLOID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IV FLUID BAGS MARKET SIZE, BY COLLOID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IV FLUID BAGS MARKET SIZE, BY COLLOID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL IV FLUID BAGS MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL IV FLUID BAGS MARKET SIZE, BY ALBUMIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IV FLUID BAGS MARKET SIZE, BY ALBUMIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL IV FLUID BAGS MARKET SIZE, BY DEXTRANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL IV FLUID BAGS MARKET SIZE, BY DEXTRANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL IV FLUID BAGS MARKET SIZE, BY DEXTRANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL IV FLUID BAGS MARKET SIZE, BY GELATINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL IV FLUID BAGS MARKET SIZE, BY GELATINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL IV FLUID BAGS MARKET SIZE, BY GELATINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL IV FLUID BAGS MARKET SIZE, BY HYDROXYETHYL STARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL IV FLUID BAGS MARKET SIZE, BY HYDROXYETHYL STARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IV FLUID BAGS MARKET SIZE, BY HYDROXYETHYL STARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL IV FLUID BAGS MARKET SIZE, BY DEXTROSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL IV FLUID BAGS MARKET SIZE, BY DEXTROSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL IV FLUID BAGS MARKET SIZE, BY DEXTROSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL IV FLUID BAGS MARKET SIZE, BY NORMAL SALINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL IV FLUID BAGS MARKET SIZE, BY NORMAL SALINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL IV FLUID BAGS MARKET SIZE, BY NORMAL SALINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL IV FLUID BAGS MARKET SIZE, BY RINGERS LACTATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL IV FLUID BAGS MARKET SIZE, BY RINGERS LACTATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL IV FLUID BAGS MARKET SIZE, BY RINGERS LACTATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL IV FLUID BAGS MARKET SIZE, BY NON-PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL IV FLUID BAGS MARKET SIZE, BY NON-PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL IV FLUID BAGS MARKET SIZE, BY NON-PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL IV FLUID BAGS MARKET SIZE, BY BIOPOLYMER FILMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL IV FLUID BAGS MARKET SIZE, BY BIOPOLYMER FILMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL IV FLUID BAGS MARKET SIZE, BY BIOPOLYMER FILMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL IV FLUID BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL IV FLUID BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL IV FLUID BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IV FLUID BAGS MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL IV FLUID BAGS MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL IV FLUID BAGS MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL IV FLUID BAGS MARKET SIZE, BY 100-250 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL IV FLUID BAGS MARKET SIZE, BY 100-250 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL IV FLUID BAGS MARKET SIZE, BY 100-250 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL IV FLUID BAGS MARKET SIZE, BY 250-500 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL IV FLUID BAGS MARKET SIZE, BY 250-500 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL IV FLUID BAGS MARKET SIZE, BY 250-500 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL IV FLUID BAGS MARKET SIZE, BY 500-1000 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL IV FLUID BAGS MARKET SIZE, BY 500-1000 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL IV FLUID BAGS MARKET SIZE, BY 500-1000 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL IV FLUID BAGS MARKET SIZE, BY ABOVE 1000 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL IV FLUID BAGS MARKET SIZE, BY ABOVE 1000 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL IV FLUID BAGS MARKET SIZE, BY ABOVE 1000 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL IV FLUID BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL IV FLUID BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL IV FLUID BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL IV FLUID BAGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL IV FLUID BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL IV FLUID BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL IV FLUID BAGS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL IV FLUID BAGS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL IV FLUID BAGS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL IV FLUID BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL IV FLUID BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL IV FLUID BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL IV FLUID BAGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL IV FLUID BAGS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL IV FLUID BAGS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL IV FLUID BAGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL IV FLUID BAGS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL IV FLUID BAGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL IV FLUID BAGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL IV FLUID BAGS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL IV FLUID BAGS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL IV FLUID BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS IV FLUID BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA IV FLUID BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL IV FLUID BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. GCC IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GCC IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. GCC IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 168. GCC IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 169. GCC IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 170. GCC IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 171. GCC IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 172. GCC IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. GCC IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. G7 IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. G7 IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. G7 IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 195. G7 IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 196. G7 IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 197. G7 IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 198. G7 IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 199. G7 IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. G7 IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. NATO IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NATO IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. NATO IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 204. NATO IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 205. NATO IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 206. NATO IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 207. NATO IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 208. NATO IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. NATO IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL IV FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES IV FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA IV FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA IV FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA IV FLUID BAGS MARKET SIZE, BY COLLOID, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA IV FLUID BAGS MARKET SIZE, BY CRYSTALLOID, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA IV FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA IV FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA IV FLUID BAGS MARKET SIZE, BY BAG VOLUME, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA IV FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA IV FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)